Your browser doesn't support javascript.
loading
Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry. / Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19.
Casas-Rojo, J M; Antón-Santos, J M; Millán-Núñez-Cortés, J; Lumbreras-Bermejo, C; Ramos-Rincón, J M; Roy-Vallejo, E; Artero-Mora, A; Arnalich-Fernández, F; García-Bruñén, J M; Vargas-Núñez, J A; Freire-Castro, S J; Manzano-Espinosa, L; Perales-Fraile, I; Crestelo-Viéitez, A; Puchades-Gimeno, F; Rodilla-Sala, E; Solís-Marquínez, M N; Bonet-Tur, D; Fidalgo-Moreno, M P; Fonseca-Aizpuru, E M; Carrasco-Sánchez, F J; Rabadán-Pejenaute, E; Rubio-Rivas, M; Torres-Peña, J D; Gómez-Huelgas, R.
Affiliation
  • Casas-Rojo JM; Servicio de Medicina Interna, H. U. Infanta Cristina, Parla, Madrid, España.
  • Antón-Santos JM; Servicio de Medicina Interna, H. U. Infanta Cristina, Parla, Madrid, España. Electronic address: jmanton.hugf@salud.madrid.org.
  • Millán-Núñez-Cortés J; Servicio de Medicina Interna, H. U. Gregorio Marañón, Madrid, España.
  • Lumbreras-Bermejo C; Servicio de Medicina Interna, H. U. 12 de Octubre, Madrid, España.
  • Ramos-Rincón JM; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, España.
  • Roy-Vallejo E; Servicio de Medicina Interna, H. U. La Princesa, Madrid, España.
  • Artero-Mora A; Servicio de Medicina Interna, H. U. Dr. Peset, Valencia, España.
  • Arnalich-Fernández F; Servicio de Medicina Interna, H. U. La Paz, Madrid, España.
  • García-Bruñén JM; Servicio de Medicina Interna, H. U. Miguel Servet, Zaragoza, España.
  • Vargas-Núñez JA; Servicio de Medicina Interna, H. U. Puerta de Hierro, Majadahonda, Madrid, España.
  • Freire-Castro SJ; Servicio de Medicina Interna, H. U. de A Coruña, A Coruña, España.
  • Manzano-Espinosa L; Servicio de Medicina Interna, H. U. Ramón y Cajal, Madrid, España.
  • Perales-Fraile I; Servicio de Medicina Interna, H. U. Infanta Sofía, San Sebastián de los Reyes, Madrid, España.
  • Crestelo-Viéitez A; Servicio de Medicina Interna, H. Royo Villanova, Zaragoza, España.
  • Puchades-Gimeno F; Facultad de Medicina, Universidad Católica de Valencia, Valencia, España.
  • Rodilla-Sala E; Servicio de Medicina Interna, H. de Sagunto, Sagunto, Valencia, España.
  • Solís-Marquínez MN; Servicio de Medicina Interna, H. U. San Agustín, Avilés, Asturias, España.
  • Bonet-Tur D; Servicio de Medicina Interna, H. U. San Juan de Alicante, Sant Joan d'Alacant, Alicante, España.
  • Fidalgo-Moreno MP; Servicio de Medicina Interna, H. U. del Henares, Madrid, España.
  • Fonseca-Aizpuru EM; Servicio de Medicina Interna, H. U. de Cabueñes, Gijón, Asturias, España.
  • Carrasco-Sánchez FJ; Servicio de Medicina Interna, H. U. Juan Ramón Jiménez, Huelva, España.
  • Rabadán-Pejenaute E; Servicio de Medicina Interna, H. U. San Pedro, Logroño, La Rioja, España.
  • Rubio-Rivas M; Servicio de Medicina Interna, H. U. de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
  • Torres-Peña JD; Servicio de Medicina Interna, H. U. Reina Sofía, Córdoba, España.
  • Gómez-Huelgas R; Servicio de Medicina Interna, H. Regional Universitario de Málaga, Málaga, España. Electronic address: rgh@uma.es.
Rev Clin Esp (Barc) ; 220(8): 480-494, 2020 Nov.
Article in En, Es | MEDLINE | ID: mdl-32762922
ABSTRACT

BACKGROUND:

Spain has been one of the countries most affected by the COVID-19 pandemic.

OBJECTIVE:

To create a registry of patients with COVID-19 hospitalized in Spain, in order to improve our knowledge of the clinical, diagnostic, therapeutic, and prognostic aspects of this disease.

METHODS:

A multicentre retrospective cohort study, including consecutive patients hospitalized with confirmed COVID-19 throughout Spain. Epidemiological and clinical data, additional tests at admission and at seven days, treatments administered, and progress at 30 days of hospitalization were collected from electronic medical records.

RESULTS:

Up to June 30th 2020, 15,111 patients from 150 hospitals were included. Their median age was 69.4 years (range 18-102 years) and 57.2% were male. Prevalences of hypertension, dyslipidemia, and diabetes mellitus were 50.9%, 39.7%, and 19.4%, respectively. The most frequent symptoms were fever (84.2%) and cough (73.5%). High values of ferritin (73.5%), lactate dehydrogenase (73.9%), and D-dimer (63.8%), as well as lymphopenia (52.8%), were frequent. The most used antiviral drugs were hydroxychloroquine (85.6%) and lopinavir/ritonavir (61.4%); 33.1% developed respiratory distress. Overall mortality rate was 21.0%, with a marked increase with age (50-59 years 4.7%, 60-69 years 10.5%, 70-79 years 26.9%, ≥80 years 46.0%).

CONCLUSIONS:

The SEMI-COVID-19 Network provides data on the clinical characteristics of patients with COVID-19 hospitalized in Spain. Patients with COVID-19 hospitalized in Spain are mostly severe cases, as one in three patients developed respiratory distress and one in five patients died. These findings confirm a close relationship between advanced age and mortality.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En / Es Journal: Rev Clin Esp (Barc) Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En / Es Journal: Rev Clin Esp (Barc) Year: 2020 Document type: Article